TScan Therapeutics is developing engineered T cell receptor therapies, with TSC-101 targeting HA-2 for acute leukemia. See ...
Inflammation serves crucial biological functions, such as in the response to infections and healing. But persistent or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback